Lyric vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Lyric

EmergingSupply Chain

AI Supply Chain Decision Intelligence

Raised $43.5M Series B (Aug 2025) led by Insight Partners. 500% revenue growth since stealth exit. Modular AI logic library for Fortune 500 supply chain scenario modeling.

About

Lyric builds reusable AI-powered supply chain decision intelligence for Fortune 500 companies, providing a modular library of supply chain logic for inventory optimization, order forensics, network planning, and transportation modeling. The company raised $43.5 million in Series B financing in August 2025 led by Insight Partners, reporting 500% revenue growth since emerging from stealth. Total funding has reached $67 million.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.